<DOC>
	<DOCNO>NCT02644239</DOCNO>
	<brief_summary>The ketogenic diet non-pharmacological treatment prescribe especially child indicate specialized center patient refractory epilepsy . The composition ketogenic diet base high-fat , low-carbohydrate , moderate protein content , production ketone body probable mechanism involve control seizure . The relationship treatment ketogenic diet change oxidative characteristic , physical lipid well establish . Some study show significant increase total cholesterol triglycerides child treat ketogenic diet , study show change lipid profile long term appear significant , beyond influence change coronary heart disease unknown . The study perform last two decade show besides change lipid profile , oxidative modification lipoproteins essential initiation progression atherosclerosis physical property lipoproteins also appear involved process , suggest particle size lipoprotein , analysis subfractions provide detail cardiovascular risk . Thus , projetct aim compare effect classical ketogenic diet ketogenic diet modify low content saturate fatty acid higher content monounsaturated polyunsaturated , oxidative change LDL , lipidomic profile , concentration antioxidant production inflammatory cytokine subfractions LDL HDL child adolescents refractory epilepsy , clinical effect control epilepsy .</brief_summary>
	<brief_title>Impact Ketogenic Diet Lipoproteins Refractory Epilepsy</brief_title>
	<detailed_description>Controlled clinical trial compose child adolescent age 1 19 year refractory epilepsy drug polytherapy ( antiepileptic drug ) . Children sex include . The control group receive diet classical ketogenic case group receive ketogenic diet modify reduction least 20 % supply saturate fat increase &gt; 50 % acid supply monounsaturated fatty , increase &gt; 50 % acid content polyunsaturated fatty low ratio w6 / w3 least 50 % compare classical diet use control group . Patients follow 3 time : baseline , 3 month 6 month intervention . Exclusion criterion : Children adolescent use type hormone replacement ; Children adolescents present diagnosis diabetes mellitus hypothyroidism hyperthyroidism ; Children adolescents acute illness heart disease kidney disease prevent indication DC evaluate medical history complete physical examination neurologist doctor charge clinic . Outcome Measures : . Characterize sample demographic ( gender , age ) , scioeconomic , quality life clinical ; B . To assess dietary intake food record ; c. Evaluate anthropometric profile classify nutritional status ( Z score body mass index age [ ZBMI / I ] ) ; d. Assess body composition ( percentage fat , lean mass , total body water phase angle ) ; e. Determine concentration cholesterol triglyceride , lipoprotein ( TC , TG , LDL HDL ) ; f. Determine concentration apolipoproteins : APOA-1 APO-B ; g. Detect concentration ketone body plasma ( β-hydroxybutyrate ) ; H. Detecting LDL ( - ) oxidize LDL plasma ; . To detect anti-LDL autoantibody ( - ) anti-oxLDL autoantibody plasma ; j . Determine subfractions HDL , LDL high LDL particle size ; k. To evaluate concentration non-esterified fatty acid ( NEFAs ) ; l. Assess concentration fatty acids plasma ; m. To assess concentration substance reactive thiobarbituric acid ( TBARS ) plasma . n. Determine concentration antioxidant plasma : α-tocopherol , beta-carotene retinol . O . Determining lipidomic plasma profile gather lipid specie class associate risk cardiovascular disease ; P. Detecting inflammatory marker : Tumor necrosis factor ( TNF-α ) , interleukin ( IL-6 ) plasma . Q . Determine concentration hepatic enzyme R. Determine leptin , adiponectin , ghrelin resistin S. To evaluate liver ultrasound carotid ultrasound</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Drug Resistant Epilepsy</mesh_term>
	<criteria>Participate study child adolescent sex age 119 year diagnose refractory epilepsy drug polytherapy ( antiepileptic drug ) indication treatment KD . Children adolescent use type hormonal replacement ; Children adolescents submit diagnosis diabetes mellitus hypothyroidism hyperthyroidism ; Children adolescents show acute disorder heart disease kidney disease .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>